Researchers provide evidence-based suggestions for nutritional evaluation, treatment, and monitoring in patients taking anti-obesity medications (AOMs).
By Pooja Toshniwal PahariaReviewed by Danielle Ellis, B.Sc.Jun 18 2024 In a recent review published in Obesity, researchers provide evidence-based suggestions for nutritional evaluation, treatment, and monitoring in patients taking anti-obesity medications .
About the review In the present narrative review, researchers provide dietary advice for patients using new anti-obesity drugs based on PubMed data, including publication reference lists, emphasizing dietary, nutritional, weight reduction, obesity, low-calorie diets, malnutrition, and bariatric recommendations.
Clinical research has demonstrated that tirzepatide and semaglutide help with food control-related aspects, such as fullness, food cravings, and hunger. The Semaglutide Treatment Effect in People with Obesity -1 trial reported that patients who received 2.40 mg of semaglutide once weekly lost an average of 15% of their body weight, compared to 2.4% among placebo recipients.
No one diet pattern has proven superior concerning weight reduction; however, the Mediterranean diet and plant-based diets have repeatedly been linked to better health, including decreased cardiovascular disease and death risks. The United States Department of Agriculture offers services to help individuals eat properly and reach their nutritional objectives in a budget-friendly way.
Blood Blood Pressure Cardiometabolic Cardiovascular Disease Diet Drugs Food Malnutrition Placebo Protein Research Semaglutide Weight Loss
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers develop new method to remove blood cells in leukemia patients while building new blood systemResearchers have developed an approach to 'deleting' a blood system affected by leukemia while simultaneously building up a new, healthy system with donor blood stem cells. Writing in the journal Nature, the team reports on the promising results obtained in animal experiments and with human cells in the laboratory.
Read more »
Researchers design new regenerative medicine therapy to accelerate diabetic wound repairResearchers at the Icahn School of Medicine at Mount Sinai have designed a regenerative medicine therapy to speed up diabetic wound repair.
Read more »
Researchers develop new tool for better classification of inherited disease-causing variantsResearchers from Children's Hospital of Philadelphia (CHOP), the Perelman School of Medicine at the University of Pennsylvania, and the National Cancer Institute (NCI) of the National Institutes of Health have developed a new tool that allows scientists to annotate variant data from large-scale studies with clinically-focused classifications for...
Read more »
New Zealand researchers find more vape stores in deprived areas and near schoolsNew University of Canterbury research has found vape stores are proliferating in Aotearoa New Zealand's most deprived communities—with many also located near schools.
Read more »
Researchers develop new light-controlled 'off switch' for brain cellsResearchers from Duke-NUS Medical School have found that a new class of light-sensitive proteins are capable of turning off brain cells with light, offering scientists an unprecedentedly effective tool to investigate brain function.
Read more »
Researchers discover potential new therapy for lethal metabolomic diseaseResearchers at the Abimael Laboratory of Neurometabolism and the Neurometabolomics & Neuroinformatics core at Mount Sinai have discovered a potential new therapy, improved an existing treatment, and identified a disease biomarker in a mouse model of a lethal neurometabolic disease in humans.
Read more »